about
Development of targeted therapies in treatment of glioblastomaOveractive bone morphogenetic protein signaling in heterotopic ossification and Duchenne muscular dystrophyBMP9 is a proliferative and survival factor for human hepatocellular carcinoma cellsBMP7 gene transfer via gold nanoparticles into stroma inhibits corneal fibrosis in vivoAnti-wrinkle effect of bone morphogenetic protein receptor 1a-extracellular domain (BMPR1a-ECD)Reconstruction of radial bone defect using gelatin sponge and a BMP-2 combination graft.Gene gun transferring-bone morphogenetic protein 2 (BMP-2) gene enhanced bone fracture healing in rabbits.Effects of bioactive glass S53P4 or beta-tricalcium phosphate and bone morphogenetic protein-2 and bone morphogenetic protein-7 on osteogenic differentiation of human adipose stem cellsGenetic variation in bone morphogenetic proteins and breast cancer risk in hispanic and non-hispanic white women: The breast cancer health disparities study.Recombinant Human Bone Morphogenetic Protein-2 in Posterolateral Spinal Fusion: What's the Right Dose?Bone morphogenetic protein 9 overexpression reduces osteosarcoma cell migration and invasion.Effective treatment of a steroid-induced femoral neck fracture nonunion with a once-weekly administration of teriparatide in a rheumatoid patient: a case report.The influence of genetic ancestry and ethnicity on breast cancer survival associated with genetic variation in the TGF-β-signaling pathway: The Breast Cancer Health Disparities Study.Effects of exogenous recombinant human bone morphogenic protein-7 on the corneal epithelial mesenchymal transition and fibrosis.BMPs as therapeutic targets and biomarkers in astrocytic glioma.Pluripotency transcription factors in the pathogenesis of colorectal cancer and implications for prognosis.Bone morphogenetic protein 2 inhibits hepatocellular carcinoma growth and migration through downregulation of the PI3K/AKT pathway.Adenovirus mediated knockdown of bone morphogenetic protein 2 inhibits human lung cancer growth and invasion in vitro and in vivo.Contextual effect of repression of bone morphogenetic protein activity in prostate cancer.Association of genetic variants of BMP4 with type 2 diabetes mellitus and clinical traits in a Chinese Han population.Annexin-enriched osteoblast-derived vesicles act as an extracellular site of mineral nucleation within developing stem cell cultures.Rapamycin inhibits BMP-7-induced osteogenic and lipogenic marker expressions in fetal rat calvarial cells.Combinatorial Signal Perception in the BMP Pathway.Demineralized dentin matrix composite collagen material for bone tissue regeneration.Cancer after spinal fusion: the role of bone morphogenetic protein.Over-sulfated chondroitin sulfate derivatives induce osteogenic differentiation of hMSC independent of BMP-2 and TGF-β1 signalling.Bone morphogenetic protein-5 and early endothelial outgrowth cells (eEOCs) in acute ischemic kidney injury (AKI) and 5/6-chronic kidney disease.The activin-βA/BMP-2 chimera AB204 is a strong stimulator of adipogenesis.Segmental mandibular bone reconstruction with a carbonate-substituted hydroxyapatite-coated modular endoprosthetic poly(ɛ-caprolactone) scaffold in Macaca fascicularis.Osteoblastic differentiation and cell calcification of adamantinomatous craniopharyngioma induced by bone morphogenetic protein-2.An operational view of intercellular signaling pathways.Optimizing Osteogenic Differentiation of Ovine Adipose-Derived Stem Cells by Osteogenic Induction Medium and FGFb, BMP2, or NELL1 In Vitro
P2860
Q26778787-8F74C991-54F0-4E05-83D1-33B540BBD161Q26864900-EA1FF05E-E150-4A33-AEE8-6AC9C48DC3DBQ28296361-97066F32-6317-43BF-99EA-FA95B616EF49Q31120997-3F031FC6-DFBD-4344-90D1-90A84962B716Q34049412-11B34CDE-DC0B-47DB-8054-4BF0E8C51542Q34049514-3938541C-A77D-4DC2-B84C-C0D8CEC62E39Q36492597-FE18A3D7-16C3-42AB-A201-27F8C320EDBCQ36520237-77197A0D-C507-41CD-97AD-2FE05518FE13Q36841890-183878A1-C77A-45A4-ADEE-4CC7E695E48BQ37030595-985A1EF1-2260-4C63-971C-71676A2DF0C2Q37462563-8761A385-0FAA-4E18-ABCB-75317476E84FQ37470087-C17312E1-5EED-48C4-9A58-3C6E1063467FQ37624119-522A5132-A8CE-49FB-93C8-927D01575983Q37714515-7A979C07-5D5F-4D4E-B1C3-CAF852B1FBD0Q38216033-3647CFAA-47A4-4C2E-A0F0-DFD3522A935EQ38390837-06626581-4C9E-4E4B-9FD0-2B418A164DE2Q39020596-1BF97E6D-CCAD-452E-9AD9-1AD2E26C7C86Q39214413-4E959E3D-4996-4116-9C2C-BDA32700FC03Q41859712-16D5339C-425E-45F4-B30B-6BECD11B0A4AQ42181656-6CAEFE3A-B5ED-4682-8A28-0C8D05406909Q42282500-3C2A5DD2-3F4B-49B5-A0D2-B701EE50C345Q42434844-61A347F8-8412-4239-BD71-E5D60D56FB04Q42797781-6526909A-83FB-44B4-824C-55EA3E8B9108Q42816634-8D389D75-A12F-4455-ACE1-9D91F2B05875Q43622100-BDFF2974-7198-4C2B-B47B-000A5A621816Q44528474-6B017922-D6AF-477D-A68B-208B072F37CBQ44607761-44815430-7F90-4FAF-82E8-378B483D5C8EQ46142386-91478ADF-077F-4D8F-BEB0-5FF9E2D90770Q46390381-68C1AA4C-3AD9-4AEB-916D-32A7A3223292Q51007351-2D8A10B2-FE99-4DCA-9468-20B06CB9FC1DQ55166880-BE73AA5F-537E-453C-A90D-613B3114759EQ57821336-C24A21EC-1D24-498F-90A6-7C439EC3EFED
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
BMPs and their clinical potentials
@ast
BMPs and their clinical potentials
@en
BMPs and their clinical potentials
@nl
type
label
BMPs and their clinical potentials
@ast
BMPs and their clinical potentials
@en
BMPs and their clinical potentials
@nl
prefLabel
BMPs and their clinical potentials
@ast
BMPs and their clinical potentials
@en
BMPs and their clinical potentials
@nl
P2860
P3181
P1433
P1476
BMPs and their clinical potentials
@en
P2860
P304
P3181
P356
10.5483/BMBREP.2011.44.10.619
P407
P577
2011-10-01T00:00:00Z